 | Up a level |
Amminger, G Paul; Rice, Simon; Davey, Christopher G; Quinn, Amelia L; Hermens, Daniel F; Zmicerevska, Natalia; Nichles, Alissa; Hickie, Ian; Incerti, Lisa; Weller, Amber; Joseph, Sarah; Hilton, Zarah; Pugh, Charlotte; Rayner, Madeline; Reid, Nate; Ratheesh, Aswin; Yung, Alison R; Yuen, Hok Pan; Mackinnon, Andrew; Hetrick, Sarah; ... (2024). The Addition of Fish Oil to Cognitive Behavioural Case Management for Youth Depression (YoDA-F): A Randomised, Double-Blind, Placebo-Controlled, Multicentre Clinical Trial. Biological psychiatry, 95(5), pp. 426-433. Elsevier 10.1016/j.biopsych.2023.06.015
Youn, Sarah; Mamsa, Somayra; Allott, Kelly; Berger, Maximus; Polari, Andrea; Rice, Simon; Schmaal, Lianne; Wood, Stephen; Lavoie, Suzie (2023). Acceptability and feasibility of a multidomain harmonized data collection protocol in youth mental health. Early intervention in psychiatry, 17(5), pp. 512-518. Wiley 10.1111/eip.13346
Susai, Subash Raj; Healy, Colm; Mongan, David; Heurich, Meike; Byrne, Jonah F; Cannon, Mary; Cagney, Gerard; Wynne, Kieran; Markulev, Connie; Schäfer, Miriam R; Berger, Maximus; Mossaheb, Nilufar; Schlögelhofer, Monika; Smesny, Stefan; Hickie, Ian B; Berger, Gregor E; Chen, Eric Y H; de Haan, Lieuwe; Nieman, Dorien H; Nordentoft, Merete; ... (2022). Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis. Translational psychiatry, 12(1), p. 454. Nature Publishing Group 10.1038/s41398-022-02217-0
Cheng, Nicholas; McLaverty, Alison; Nelson, Barnaby; Markulev, Connie; Schäfer, Miriam R; Berger, Maximus; Mossaheb, Nilufar; Schlögelhofer, Monika; Smesny, Stefan; Hickie, Ian B; Berger, Gregor E; Chen, Eric Y H; de Haan, Lieuwe; Nieman, Dorien H; Nordentoft, Merete; Riecher-Rössler, Anita; Verma, Swapna; Street, Rebekah; Thompson, Andrew; Yuen, Hok Pan; ... (2022). Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial. BJPsych open, 8(5), e165. The Royal College of Psychiatrists 10.1192/bjo.2022.572
Berger, Maximus; Amminger, G Paul; McGregor, Iain S (2022). Medicinal cannabis for the treatment of anxiety disorders. Australian journal of general practice, 51(8), pp. 586-592. Royal Australian College of General Practitioners 10.31128/AJGP-04-21-5936
Raj Susai, Subash; Mongan, David; Healy, Colm; Cannon, Mary; Cagney, Gerard; Wynne, Kieran; Byrne, Jonah F; Markulev, Connie; Schäfer, Miriam R; Berger, Maximus; Mossaheb, Nilufar; Schlögelhofer, Monika; Smesny, Stefan; Hickie, Ian B; Berger, Gregor E; Chen, Eric Y H; de Haan, Lieuwe; Nieman, Dorien H; Nordentoft, Merete; Riecher-Rössler, Anita; ... (2022). Machine learning based prediction and the influence of complement - coagulation pathway proteins on clinical outcome: results from the NEURAPRO trial. Brain, behavior, and immunity, 103, pp. 50-60. Elsevier 10.1016/j.bbi.2022.03.013
Michel, Chantal; Berger, Maximus; Mossaheb, Nilufar; Kindler, Jochen (2021). Editorial: Clinical High Risk for Psychosis: From Epidemiological Findings to Neurobiological Underpinnings of Treatment Response and Outcome. Frontiers in psychiatry, 12 Frontiers 10.3389/fpsyt.2021.790810
Hartmann, Jessica A; Schmidt, Stefanie J.; McGorry, Patrick D; Berger, Maximus; Berger, Gregor E; Chen, Eric Y H; de Haan, Lieuwe; Hickie, Ian B; Lavoie, Suzie; Markulev, Connie; Mossaheb, Nilufar; Nieman, Dorien H; Nordentoft, Merete; Polari, Andrea; Riecher-Rössler, Anita; Schäfer, Miriam R; Schlögelhofer, Monika; Smesny, Stefan; Thompson, Andrew; Verma, Swapna K; ... (2020). Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial. Behaviour research and therapy, 124, p. 103527. Elsevier 10.1016/j.brat.2019.103527
